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Virus-Induced

Introduction
Viral infection often predisposes to bacterial superinfection. This has been attributed to the reduction of granulocyte-numbers (neutropenia) triggered by high IFN-I-levels treated patients bacterial infections occur more frequently [4] . Neutropenia is also a side .
. This control of bacteria. Pseudomonas aeruginosa which accounts for approximately 10 % of clinical infections and carries a high mortality rate [7] . This ubiquitous and predominantly extracellularly living bacterium is a facultative , P. aeruginosa-infections can develop .
(granulocytes) are necessary for control of respiratory P. aeruginosa-. For systemic P. aeruginosa-infections the role of neutrophils compared to macrophages is still P. aeruginosa . Lysozyme-2 -/-mice were disabled to clear P. aeruginosa mice were protected against a respiratory infection with P. aeruginosa [17] . Treatment with human lysozyme could reduce the bacterial burden in lungs during a respiratory P. aeruginosa . bronchial epithelial cells [17] and can be induced in hepatocytes [19] .
In order to examine further IFN-I induced mechanisms impairing the innate immune defense against P. aeruginosa macrophages in the systemic P. aeruginosa-infection and then compared different inducers
Ifnar
-/-mice. We found that neutrophils are essential to clear the bacterium after it has been taken up by macrophages The disease score was determined as follows. 0 (no symptoms) = mice appeared completely healthy were considered dead by disease in the survival analysis.
Determination of P. aeruginosa CFUs -1
Antipseudomonal activity assay P. aeruginosa yield biological replicates. 
Flow Cytometry (FACS)
Statistical analysis t Ethics Statement
with the German laws for animal protection and with the institutional according to the German laws for animal protection and to the institutional guidelines of the Ontario Cancer Institute.
Results
To get insight into the processes after intravenous infection with Pseudomonas aeruginosa granulocytes in liver and spleen.
P. aeruginosa from the P. aeruginosa has with its high amount of macrophages potential to uptake bacteria and was therefore 
Virus-induced IFN-I limits the control of P. aeruginosa, creates neutropenia and blunts the expression of lysozyme-II in the liver
To study the effect of viral infection on the innate immune defense against P. aeruginosa 7
P. aeruginosa. The combination of viral
To determine whether virus-induced IFN-I affects the control of P. aeruginosa, we infected wild-type and Ifnar -/-mice (which lack the receptor for IFN-I) with P. aeruginosa in Ifnar
Ifnar -/-mice cleared P. aeruginosa Type I interferon induction by virulent P. aeruginosa contributes to pathogenicity P. aeruginosa can have a deteriorating effect on the bacterial clearance as well. Therefore we included the more virulent strain P. aeruginosa in patients and was previously determined to be highly virulent in an acute murine airway . of the genomes could give additional hints for the cause of potential differences in IFN-I signaling.
Lysozyme-chloride has already reached clinical attention. The here described association between reduced lysozyme-expression and the course of P. aeruginosa-infection suggests that a treatment with human lysozyme could compensate the loss of endogenous lysozymeproduction and thereby improve the outcome of P. aeruginosa bloodstream-infections in patients.
P. aeruginosa during a systemic infection and the cooperation with granulocytes as essential for the control of the bacteria. Furthermore we found that the induction of high systemic levels of IFN-I by LCMV exacerbate P. aeruginosa induced by poly(I:C) or the bacterial infection itself impair the clearance of P. aeruginosa in understand processes that occur in lethal infections with P. aeruginosa. 
